NSPR
insider transactionsInspireMD, Inc. — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
Cluster buy signal: Multiple insiders at the same company buying around the same time — often a stronger signal than a single buy. 4 different insiders made open-market purchases in the last 365 days, totalling $348.8K.
Net shares · 365d
+87.8K
174.7K buy · 86.9K sell
Net value · 365d
$222.0K
$348.8K in · $126.9K out
Sentiment · 365d
Net buying
73% buying · 27% selling
Open-market trades · 365d
24
174.7K buy · 86.9K sell
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
-
Buy·P
Director
$17.5K
20.0K sh · $0.88
Own +3%
-
Sell·S
Chief Commercial Officer
$23.0K
22.8K sh · $1.01
Own -2%
-
Buy·P
Director
$5.8K
5.0K sh · $1.15
Own +1%
-
Buy·P
Director
$11.6K
10.0K sh · $1.16
Own +2%
-
Sell·S
Chief Commercial Officer
$4.7K
2.9K sh · $1.59
Own -0%
-
Sell·S
Chief Commercial Officer
$3.2K
2.0K sh · $1.60
Own -0%
-
Sell·S
Chief Commercial Officer
$4.7K
2.9K sh · $1.63
Own -0%
-
Sell·S
Chief Commercial Officer
$8.2K
5.0K sh · $1.65
Own -0%
-
Sell·S
Chief Commercial Officer
$20.5K
12.4K sh · $1.65
Own -1%
-
Sell·S
Chief Commercial Officer
$7.9K
4.8K sh · $1.66
Own -0%
-
Sell·S
Chief Commercial Officer
$13.2K
8.4K sh · $1.57
Own -1%
-
Sell·S
Chief Commercial Officer
$28.5K
17.6K sh · $1.62
Own -1%
-
Sell·S
Chief Commercial Officer
$4.7K
3.0K sh · $1.59
Own -0%
-
Sell·S
Chief Commercial Officer
$3.6K
2.2K sh · $1.61
Own -0%
-
Sell·S
Chief Commercial Officer
$4.6K
2.9K sh · $1.58
Own -0%
-
Grant·A
Director
$0
44.0K sh
Own +91%
-
Grant·A
Director
$0
88.1K sh
Own +147%
-
Grant·A
Director
$0
132.1K sh
Own +34%
-
Grant·A
Slosman Marvin KEY
CEO and President
$0
1.1M sh
Own +46%
-
Grant·A
Director
$0
88.1K sh
Own +33%
-
Grant·A
Director
$0
88.1K sh
Own +13%
-
Grant·A
Chief Operating Officer
$0
226.7K sh
Own +31%
-
Grant·A
Chief Financial Officer
$0
226.7K sh
Own +49%
-
Grant·A
Chief Commercial Officer
$0
453.4K sh
Own +61%
-
Grant·A
Director
$0
44.0K sh
Own +76%
-
Grant·A
Director
$0
26.3K sh
Own +31%
-
Grant·A
Director
$0
55.6K sh
Own +22%
-
Buy·P
Director
$4.9K
2.7K sh · $1.81
Own +1%
-
Buy·P
Director
$9.2K
5.1K sh · $1.81
Own +1%
-
Buy·P
Director
$9.4K
5.1K sh · $1.86
Own +1%
-
Buy·P
Director
$18.7K
10.1K sh · $1.85
Own +3%
-
Buy·P
Director
$21.8K
13.4K sh · $1.62
Own +4%
-
Grant·A
Director
$0
48.0K sh
Own +8%
-
Grant·A
Director
$0
19.0K sh
Own New
-
Grant·A
Director
$0
37.8K sh
Own +9%
-
Buy·P
Slosman Marvin KEY
CEO and President
$25.0K
10.3K sh · $2.42
Own +0%
-
Buy·P
Director
$50.0K
20.7K sh · $2.42
Own +5%
-
Buy·P
Director
$75.0K
31.0K sh · $2.42
Own +8%
-
Buy·P
Director
$100.0K
41.3K sh · $2.42
Own +7%
-
Exercise·X
Director
$0
30.6K sh
Own New
-
Exercise·X
Director
$42.3K
30.6K sh · $1.38
Own +9%
-
Exercise·X
Director
$0
87.5K sh
Own New
-
Exercise·X
Director
$120.8K
87.5K sh · $1.38
Own +26%
-
Exercise·X
Director
$0
61.2K sh
Own New
-
Exercise·X
Director
$84.5K
61.2K sh · $1.38
Own +33%
-
Exercise·X
Director
$0
30.6K sh
Own New
-
Exercise·X
Director
$42.3K
30.6K sh · $1.38
Own +6%
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| May 27, 2026 | Stuka Paul | Buy P | 20.0K | $17.5K |
| May 19, 2026 | Gleason Shane Thomas | Sell S | 22.8K | $23.0K |
| May 14, 2026 | Stuka Paul | Buy P | 5.0K | $5.8K |
| May 13, 2026 | Stuka Paul | Buy P | 10.0K | $11.6K |
| Feb 2, 2026 | Gleason Shane Thomas | Sell S | 2.9K | $4.7K |
| Feb 2, 2026 | Gleason Shane Thomas | Sell S | 2.0K | $3.2K |
| Jan 30, 2026 | Gleason Shane Thomas | Sell S | 2.9K | $4.7K |
| Jan 29, 2026 | Gleason Shane Thomas | Sell S | 5.0K | $8.2K |
| Jan 28, 2026 | Gleason Shane Thomas | Sell S | 12.4K | $20.5K |
| Jan 27, 2026 | Gleason Shane Thomas | Sell S | 4.8K | $7.9K |
| Jan 22, 2026 | Gleason Shane Thomas | Sell S | 8.4K | $13.2K |
| Jan 21, 2026 | Gleason Shane Thomas | Sell S | 17.6K | $28.5K |
| Jan 20, 2026 | Gleason Shane Thomas | Sell S | 3.0K | $4.7K |
| Jan 16, 2026 | Gleason Shane Thomas | Sell S | 2.2K | $3.6K |
| Jan 15, 2026 | Gleason Shane Thomas | Sell S | 2.9K | $4.6K |
| Jan 14, 2026 | COHEN RAYMOND W | Grant A | 44.0K | $0 |
| Jan 14, 2026 | Ward Scott R. | Grant A | 88.1K | $0 |
| Jan 14, 2026 | Stuka Paul | Grant A | 132.1K | $0 |
| Jan 14, 2026 | Slosman Marvin KEY | Grant A | 1.1M | $0 |
| Jan 14, 2026 | BERMAN MICHAEL | Grant A | 88.1K | $0 |
| Jan 14, 2026 | ROUBIN GARY S | Grant A | 88.1K | $0 |
| Jan 14, 2026 | Tommasoli Andrea | Grant A | 226.7K | $0 |
| Jan 14, 2026 | Lawless Michael A KEY | Grant A | 226.7K | $0 |
| Jan 14, 2026 | Gleason Shane Thomas | Grant A | 453.4K | $0 |
| Jan 14, 2026 | Dearen Danny L. | Grant A | 44.0K | $0 |
| Dec 30, 2025 | Arnold Kathryn | Grant A | 26.3K | $0 |
| Dec 30, 2025 | Arnold Kathryn | Grant A | 55.6K | $0 |
| Dec 9, 2025 | Stuka Paul | Buy P | 2.7K | $4.9K |
| Dec 9, 2025 | Stuka Paul | Buy P | 5.1K | $9.2K |
| Dec 5, 2025 | Stuka Paul | Buy P | 5.1K | $9.4K |
| Dec 4, 2025 | Stuka Paul | Buy P | 10.1K | $18.7K |
| Nov 12, 2025 | Stuka Paul | Buy P | 13.4K | $21.8K |
| Oct 7, 2025 | ROUBIN GARY S | Grant A | 48.0K | $0 |
| Sep 15, 2025 | Kester Thomas J | Grant A | 19.0K | $0 |
| Sep 15, 2025 | Kester Thomas J | Grant A | 37.8K | $0 |
| Jul 30, 2025 | Slosman Marvin KEY | Buy P | 10.3K | $25.0K |
| Jul 30, 2025 | Stuka Paul | Buy P | 20.7K | $50.0K |
| Jul 30, 2025 | Kester Thomas J | Buy P | 31.0K | $75.0K |
| Jul 30, 2025 | ROUBIN GARY S | Buy P | 41.3K | $100.0K |
| Jul 11, 2025 | Kester Thomas J | Exercise X | 30.6K | $0 |
| Jul 11, 2025 | Kester Thomas J | Exercise X | 30.6K | $42.3K |
| Jul 1, 2025 | Stuka Paul | Exercise X | 87.5K | $0 |
| Jul 1, 2025 | Stuka Paul | Exercise X | 87.5K | $120.8K |
| Jun 29, 2025 | BERMAN MICHAEL | Exercise X | 61.2K | $0 |
| Jun 29, 2025 | BERMAN MICHAEL | Exercise X | 61.2K | $84.5K |
| Jun 25, 2025 | ROUBIN GARY S | Exercise X | 30.6K | $0 |
| Jun 25, 2025 | ROUBIN GARY S | Exercise X | 30.6K | $42.3K |
About NSPR insider trading
This page tracks insider transactions for InspireMD, Inc. (NSPR) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.